How did ASMB's operating expenses trend in Q4 2024?

Assembly Biosciences' operating expenses for Q4 2024 are not currently available. However, based on the information available, it is clear that the company's focus has been on strategic initiatives and research and development activities, which have intensified in recent quarters.

Given this context, it is reasonable to assume that the company's operating expenses, including those for Q4 2024, may have been higher than previous quarters due to the increased research and development activities. However, without specific data on Q4 2024 operating expenses, this conclusion is based on an analysis of the company's overall trend and the information available regarding its operating expenses in other quarters and the factors influencing them.